Magnesium Complex
Magnesium Complex, licence 80082636: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Complexe Magnésium
- Licence holder
- Bio Lonreco Inc.
- NPN or DIN-HM
- 80082636
- Status
- Inactive licence
- Licence date
- 24 January 2018
- Revision date
- 21 February 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Magnésium: up to 400 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 300 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Magnésium: up to 400 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Citrate de magnésium | 400.0 milligramme | 400,000 µg |
| Magnésium Source : Malate de magnésium | 400.0 milligramme | 400,000 µg |
| Magnésium Source : Aspartate de magnésium | 400.0 milligramme | 400,000 µg |
Non-medicinal ingredients
Silice pyrogénée, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 1.0 Jour(s) |
Uses authorised in Canada
Aide au développement et au maintien des os et des dents. Aide à la formation de tissus. Aide au bon fonctionnement des muscles, incluant le muscle du coeur. Source d'électrolyte/Un électrolyte pour le maintien d'une bonne santé. Aide au métabolisme de l'énergie, à la formation des tissus et au développement des os. Aide à maintenir un équilibre électrolytique normal. Aide à maintenir les capacités du corps à métaboliser les nutriments.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Certaines personnes pourraient souffrir de diarrhée.
Source
Official Health Canada record, licence 80082636
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.